DAA562 |
mitochondrial ribosomal protein L41 |
Molecular |
skeletal muscle |
Human |
MRPL41 |
3.0% Decrease Gene Expression Level |
|
DAA493 |
mitochondrial ribosomal protein L48 |
Molecular |
skeletal muscle |
Human |
MRPL48 |
4.0% Decrease Gene Expression Level |
|
DAA519 |
mitochondrial ribosomal protein S15 |
Molecular |
skeletal muscle |
Human |
MRPS15 |
3.0% Decrease Gene Expression Level |
|
DAA465 |
mitochondrial ribosomal protein S22 |
Molecular |
skeletal muscle |
Human |
MRPS22 |
1.0% Decrease Gene Expression Level |
|
DAA1789 |
mitochondrial ribosomal protein S23 |
Molecular |
muscle |
Mouse |
Mrps23 |
2.0% Decrease Gene Expression Level |
|
DAA528 |
mitochondrial ribosomal protein S24 |
Molecular |
skeletal muscle |
Human |
MRPS24 |
2.0% Decrease Gene Expression Level |
|
DAA511 |
mitochondrial ribosomal protein S30 |
Molecular |
skeletal muscle |
Human |
MRPS30 |
2.0% Decrease Gene Expression Level |
|
DAA361 |
mitochondrial ribosomal protein S7 |
Molecular |
skeletal muscle |
Human |
MRPS7 |
2.0% Decrease Gene Expression Level |
|
DAA579 |
mitogen-activated protein kinase 6 |
Molecular |
skeletal muscle |
Human |
MAPK6 |
4.0% Decrease Gene Expression Level |
|
DAA1784 |
mitogen-activated protein kinase kinase 2 |
Molecular |
muscle |
Mouse |
Map2k2 |
3.0% Increase Gene Expression Level |
|
DAA1785 |
mitogen-activated protein kinase kinase 6 |
Molecular |
muscle |
Mouse |
Map2k6 |
8.0% Decrease Gene Expression Level |
|
DAA456 |
mitogen-activated protein kinase kinase kinase 15 |
Molecular |
skeletal muscle |
Human |
MAP3K15 |
8.0% Decrease Gene Expression Level |
|
DAA311 |
mitogen-activated protein kinase kinase kinase kinase 3 |
Molecular |
skeletal muscle |
Human |
MAP4K3 |
5.0% Increase Gene Expression Level |
|
DAA455 |
mixed lineage kinase domain-like |
Molecular |
skeletal muscle |
Human |
MLKL |
7.0% Decrease Gene Expression Level |
|
DAA401 |
MORN repeat containing 5 |
Molecular |
skeletal muscle |
Human |
MORN5 |
20.0% Decrease Gene Expression Level |
|
DAA642 |
Muscle atrophy (sarcopenia) |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA2592 |
Muscle characteristics change with aging |
Physiological |
muscle |
Human |
— |
— |
|
DAA643 |
Muscle fiber energy metabolism declines |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA1992 |
Muscle mass and strength loss |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA2026 |
Mutations in mitochondrial DNA accumulate |
Physiological |
heart, kidney, skeletal muscle, cerebral cortex, cerebellum |
Human |
— |
— |
|
DAA340 |
myomesin (M-protein) 2, 165kDa |
Molecular |
skeletal muscle |
Human |
MYOM2 |
5.0% Increase Gene Expression Level |
|
DAA1873 |
myosin binding protein H |
Molecular |
skeletal muscle |
Mouse |
Mybph |
37.0% Increase Gene Expression Level |
|
DAA312 |
myosin, heavy chain 8, skeletal muscle, perinatal |
Molecular |
skeletal muscle |
Human |
MYH8 |
20.0% Increase Gene Expression Level |
|
DAA1792 |
myosin, light polypeptide 6, alkali, smooth muscle and non-muscle |
Molecular |
muscle |
Mouse |
Myl6 |
5.0% Decrease Gene Expression Level |
|
DAA1793 |
myosin, light polypeptide 9, regulatory |
Molecular |
muscle |
Mouse |
Myl9 |
4.0% Decrease Gene Expression Level |
|